US Broker Ratings

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 26.3% Potential Upside Amidst Strong Growth Metrics

AptarGroup, Inc. (NYSE: ATR) is capturing investor attention with its robust market position in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a Promising 15.47% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector as a unique player with a business model focused on acquiring biopharmaceutical royalties and funding innovation. Founded in 1996..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking a Potential 39% Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a stalwart in the healthcare technology sector, is capturing investor attention with its robust market presence and promising growth metrics. With a current market cap..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 35.69% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnological space, has garnered significant attention due to its promising pipeline of therapeutics based on ribonucleic acid interference (RNAi). As a..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the Challenges Amidst a -45% Revenue Decline

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors worldwide with its innovative mRNA technology. However, recent financial metrics highlight significant challenges..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 10.98% Upside Potential in Healthcare

IQVIA Holdings, Inc. (NYSE: IQV), a titan in the healthcare sector, particularly in diagnostics and research, is making waves with its robust market presence and promising investor outlook. With a..

Masimo Corporation (MASI)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: Navigating the Glaucoma Therapy Market with a 9% Potential Upside

Glaukos Corporation (NYSE: GKOS) stands at the forefront of ophthalmic pharmaceuticals and medical technology, carving a niche in the treatment of glaucoma, corneal disorders, and retinal diseases. With a strong..

Exact Sciences Corporation (EXAS) Stock Analysis: Riding the Healthcare Wave with a 3.47% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $19.42 billion, the company..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook on a 31.63% Potential Upside

For investors keen on the healthcare sector, Neurocrine Biosciences, Inc. (NBIX) presents a compelling opportunity, especially with a significant 31.63% potential upside based on analyst ratings. As a leader in..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Biotech Leader with 32% Potential Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector, capturing investor attention with its robust market presence and promising therapeutic innovations. Headquartered in West Conshohocken, Pennsylvania, Madrigal..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 11.42% Potential Upside with Strong Revenue Growth

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is capturing investor attention with its robust financial performance and promising growth prospects. As a key player in the biotechnology sector, this San Diego-based company..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring the 19.57% Potential Upside in a High-Stakes Biotech Sector

Roivant Sciences Ltd. (ROIV), a burgeoning entity in the healthcare sector, is capturing investor attention with a notable 19.57% potential upside. This London-based biotechnology firm, with a market cap of..

HealthEquity, Inc. (HQY) Investor Outlook: Explore the 41.63% Potential Upside and Analyst Confidence

For investors navigating the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents a promising opportunity. As a leader in health information services, the company leverages technology to provide consumer-focused solutions like..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 56.45% Potential Upside in Healthcare Innovation

Individual investors looking for promising opportunities in the healthcare sector might find Waystar Holding Corp. (WAY) an intriguing candidate. The company, with its robust cloud-based solutions for healthcare payments, stands..

Novartis AG (NVS) Stock Analysis: Evaluating the 32.62% ROE and Navigating the Healthcare Giant’s Growth Path

For investors with a keen eye on the healthcare sector, Novartis AG (NYSE: NVS) presents a compelling case. The Swiss-based pharmaceutical giant, headquartered in Basel, is a prominent player in..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Robust Growth Amidst a Challenging Valuation Landscape

Medpace Holdings, Inc. (NASDAQ: MEDP) is emerging as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $16.56 billion, Medpace..

Cencora, Inc. (COR): Investor Outlook and 12.26% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a key player in the healthcare sector, is capturing investor interest with its robust market presence and promising financial outlook. Formerly known as AmerisourceBergen Corporation, Cencora..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Cardinal Health, Inc. (CAH) Stock Analysis: A Compelling 10.53% Upside Beckons Investors

Cardinal Health, Inc. (NYSE: CAH), a titan in the healthcare sector, continues to capture the attention of investors with its robust performance and promising growth potential. Headquartered in Dublin, Ohio,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds